{
    "nctId": "NCT00385177",
    "briefTitle": "Phase 1 Dose Escalation Study of SN2310 Injectable Emulsion in Patients With Advanced Solid Tumors",
    "officialTitle": "A Multicenter Phase 1 Dose Escalation Study of SN2310 Injectable Emulsion in Patients With Advanced Solid Tumors",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Neoplasms, Colorectal Neoplasms, Pancreatic Neoplasms, Pelvic Neoplasms, Lung Neoplasms",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE1",
    "allocation": "NON_RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 61,
    "primaryOutcomeMeasure": "Maximum Tolerated Dose",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Histologically or cytologically confirmed diagnosis of solid tumor with disease progression despite standard therapy and/or for which no other solid therapeutic option exists\n* ANC \\> 1,500 cell/mm3, platelets \\> 100,000/mm3 and Hgb \\> 9 g/dl\n* At least one unidimensionally measurable lesion per RECIST\n* Negative serum or urine pregnancy test, if female of childbearing potential\n\nExclusion Criteria:\n\n* Female who is pregnant or lactating\n* History of chronic diarrhea",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}